Protective effect of taurine against alendronate-induced gastric damage in rats

Fundamental and Clinical Pharmacology

Volumn 19, Issue 1, 2005, Pages 93-100

  Şener, Göksel ^a   Şehirli, Özer ^a   Cetinel, Sule ^a   Midillioǧlu, Şükrü ^a   Gedik, Nursal ^b   Ayanoǧlu Dülger, Gül ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b KASIMPASA MILITARY HOSPITAL   (Turkey)

Author keywords

Alendronate; Glutathione; Lipid peroxidalion; Myeloperoxidase; Taurine

Indexed keywords

ALENDRONIC ACID; ANTIOXIDANT; COLLAGEN; ESSENTIAL AMINO ACID; GLUTATHIONE; LIPID PEROXIDE; MALONALDEHYDE; MYELOPEROXIDASE; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; LIPID PEROXIDATION; MEMBRANE STABILIZATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PYLORUS LIGATION; RAT; STATISTICAL SIGNIFICANCE; STOMACH; STOMACH INJURY; STOMACH LAVAGE; STOMACH PH; TISSUE ULCER INDEX VALUE;

ALENDRONATE; ANIMALS; ANTIOXIDANTS; COLLAGEN; GASTRIC MUCOSA; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; PEROXIDASE; RATS; RATS, WISTAR; STOMACH; STOMACH ULCER; TAURINE;

EID: 13444256046     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2004.00310.x     Document Type: Article

References (36)

1. Martens M.G. Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review. J. Reprod. Med. (2003) 48 425-434.
2. Lowe C.E., Depew T.W., Vanner S.J., Paterson W.G., Meddings J.B. Upper gastrointestinal toxicity of alendronate. Am. J. Gastroenterol. (2000) 95 634-640.
3. Graham D.Y. What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Dig. Dis. Sci. (2002) 47 1665-1678.
4. Lanza F., Rack M.F., Simon T.J., Lombardi A., Reyes R., Suryawanshi S. Effects of alendronate on gastric and duodenal mucosa. Am. J. Gastroenterol. (1998) 93 753-757.
5. Elliot S.N., McKnight W., Davies N.M., MacNaughton W.K., Wallace J.L. Alendronate induces gastric injury and delays ulcer healing in rodents. Life Sci. (1998) 62 77-91.
6. Peter C.P., Handt L.K., Smith S.M. Esophageal irritation due to alendronate sodium tablets. Dig. Dis. Sci. (1998) 43 1998-2002.
7. Shi X., Flynn D.C., Porter D.W., Leonard S.S., Valllyathan V., Castranova V. Efficacy of taurine based compounds as hydroxyl radical scavengers in silica induced peroxidation. Ann. Clin. Lab. Sci. (1997) 27 365-374.
8. Kerai M.D., Waterfield C.J., Kenyon S.H., Asker D.S., Timbrel J.A. The effect of taurine depletion by β-alanine treatment on the susceptibility to ethanol-induced hepatic dysfunction in rats. Alcohol Alcohol. (2001) 36 29-38.
9. Egan B.M., Abdih H., Kelly C.J., Condron C. Bouchier-Hayes D.J. Effect of intravenous taurine on endotoxin-induced acute lung injury in sheep. Eur. J. Surg. (2001) 167 575-580.
10. Sato S., Yamate J., Saito T., Hosokawa T., Shigeru S., Kurasaki M. Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin. Naunyn Schmiedebergs Arch. Pharmacol. (2002) 365 277-283.
11. Ahn B.O., Kim K.H., Lee G. et al. Effects of taurine on cerulein-induced acute pancreatitis in the rat. Pharmacology (2001) 63 1-7.
12. Hamaguchi T., Azuma J., Awata N., Ohta H., Takihara K., Harada H. Reduction of doxorubicin induced cardiotoxicity in mice by taurine. Res. Commercial Chem. Pathol. Pharmacol. (1988) 59 21-30.
13. Odetti P., Pesce C., Traverso N. et al. Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes (2003) 52 499-505.
14. Rascheke P., Massoudy P., Becker B.P. Taurine protects the heart from neutrophil-induccd reperfusion injury. Free. Radic. Biol. Med. (1995) 19 461-471.
15. Allo S.N., Bagby L., Schaffer S.W. Taurine depletion, a novel mechanism for cardioprotection from regional ischemia. Am. J. Physiol. (Heart Circ. Physiol. 42) (1997) 273 H1956-H1961.
16. Gürer H., Özgüneş H., Saygin E., Ercal N. Antioxidant effect of taurine against lead-Induced oxidativc stress. Arch. Environ. Contain. Toxicol. (2001) 41 397-402.
17. Son M.W., Ko J.I., Doh H.M. et al. Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats. Arch. Pharm. Res. (1998) 21 531-536.
18. Şener G., Paskaloǧlu K., Kapucu C., Cetinel Ş., Contuk G., Ayanoǧlu-Dülger G. Octreotide ameliorates alendronat-induced gastric injury. Peptides (2004) 25 115-121.
19. Şener G., Kapucu C., Cetinel S., Cikler E., Ayanoǧlu- Dülger G. Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa. Prostaglandins Leukot. Essent. Fatty Acids (in press).
20. Bozkurt A., Yüksel M., Haklar G., Kurtel H., Yeǧen B.Ç., Alican I. Adenosine protects against indomethacin-induced gastric damage in rats. Dig. Dis. Sci. (1998) 43 1258-1263.
21. Shay H., Sun D.C.Y., Gruenstein R. A quantitative method for measuring spontaneous gastric secretion in the rat. Gastroenterology (1954) 26 906-913.
22. Hillegass L.M., Griswold D.E., Brickson B., Albrightson-Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J. Pharmacol. Methods (1990) 24 285-295.
23. Beutler E. Glutathione in red blood cell metabolism. A manual of biochemical methods. Grune & Stratton, New York, 1975, pp. 112-114.
24. Beuge J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. (1978) 52 302-311.
25. Lopez De Leon A., Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed parraffin-embedded sections. J. Histochem. Cytochem. (1985) 33 737-743.
26. Reiter R.J., Acuno-Castroviejo D., Tan D.X., Burkhardt S. Free radical-mediated molecular damage. Ann. N.Y. Acad. Sci. (2001) 939 200-215.
27. Kwiecien S., Brzozowski T., Konturek S.J. Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J. Physiol. Pharmacol. (2002) 53 39-50.
28. Natale G., Lazzeri G., Lubrano V. et al. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. Toxicol. Appl. Pharmacol. (2004) 195 62-72.
29. Son M., Kim H.K., Kim W.B., Yang J., Kim B.K. Protective effects of taurine on indomethacin-induced gastric mucosal injury. Adv. Exp. Med. Biol. (1996) 403 147-155.
30. Kearns S., Dawson J.R. Cytoprotective effect of taurine against hypochlorous acid toxicity to PC12 cells. Adv. Exp. Med. Biol. (2000) 483 563-570.
31. Saad Y.S., Al-Rikabi A.C. Protection effects of taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy (2002) 48 42-48.
32. Nakamura T., Ogasawara M., Koyama I., Nemoto M., Yoshida Y. The protective effect of taurine on the biomembrane against damage produced by oxygen radicals. Biol. Pharm. Bull. (1993) 16 970-972.
33. Fennessy F.M., Moneley D.S., Wang J.H., Kelly C.J., Bouchier-Hayes D.J. Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers. Circulation (2003) 107 410-415.
34. Kaplan B., Aricioglu A., Erbas D., Erbas S., Turkozan N. The effects of taurine on perfused heart muscle malondialdehyde levels. Gen. Pharmacol. (1993) 6 1411-1413.
35. Blank M.A., Ems B.L., Gibson G.W. et al. Non clinical model for assessing gastric effects of bisphosphonates. Dig. Dis. Sci. (1997) 42 281-288.
36. Trachtman H., Futterweit S., Maesaka J., Ma C., Valderrama E., Fuchs A. Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats. Am. J. Physiol. (1995) 269 (Pt 2) 429-438.